TARGETDX LABORATORY

TargetDx Laboratory, located in Michigan City, Indiana, is a medical device company dedicated to creating a groundbreaking blood test for the early detection of Non-Small Cell Lung Cancer (NSCLC). Our test, developed using a combination of protein biomarkers and proprietary machine learning algorithms delivers a highly sensitive and specific risk assessment for early-stage lung cancer... The pinnacle of our innovation is the Lung Cancer Detection Test 1 (LCDT1), a simple blood test with a notable 95% accuracy for detecting Stage 1 lung cancer. With LCDT1, we aim to transform lung cancer detection, facilitating earlier intervention and enhancing the quality of life for patients. Our mission is to transform lung cancer screening focusing on early, precise detection to dramatically reduce the cancer's impact. We aim to provide hope for a future with a substantially lesser burden of cancer, improving both survival and the quality of life for those affected... LCDT1 is a simple blood test..

Also known as: TargetDX Lab

Primary location: Michigan City United States